Education

Two years on, has the prescription for pharmacy recruitment changed?

Two years on, has the prescription for pharmacy recruitment changed?


A couple of years ago I dug into the vexed question of UCAS entry tariff requirements via a close analysis of pharmacy (MPharm) courses.

With UCAS beginning to add course-level details about the tariff points or qualifications people on the course actually held – a “common” tariff, along with low and high points – it became possible to compare the tariff traditionally put in front of applicants with what entry onto a course actually looks like.

I chose the four year MPharm because it is a very highly regulated course – the General Pharmaceutical Council tightly specifies course coverage and requirements, and the qualification (generally, but obviously not always) leads to a single route (the pre-registration year) into a single profession.

An MPharm is an MPharm – there’s no real signalling advantage from getting the award from one provider rather than another, so what we see in offermaking and advertising behavior is a fairly pure expression of institutional ambition.

24 months later

Coming back to the analysis two years on, we can see how these ambitions and their expression have changed over time, alongside student numbers.

[Full screen]

The focus of this visualisation is full-time first degree entry to the four-year MPharm qualification, in either the 2025 cycle or the 2027 cycle (choose via the filter at the top) The top chart looks at advertised entry tariffs (the blue dots) alongside actual entry tariffs (the orange circles) with higher and lower limits (the arrows). The grey bars show offer rates for UK 18 and 19 year old students. If you mouse over any of this you can compare two years for each provider (though some have only one year of data and some – in Scotland notably – don’t supply anything other than the advertised tariff. The bars in the lower chart show (HESA) student numbers for the pharmacy subject areas – with what would have been the last data available before tariffs were set for each of the two cycles.  

The first thing to note is that pretty much everyone has grown the size of their pharmacy offer. With current concerns about graduate destination courses that have traditionally led to a very good chance of employment are going to be popular. Pharmacy is a profession in the traditional sense – and even though the issues that the profession faces with the growth of (often unregulated) online dispensing and the shift from independent shops to large chains looking to cut costs are real, it will take a while for that perception to change among applicants and their parents or guardians.

That said, at King’s College, Manchester and Bradford, this growth has happened alongside a rise in both the entry tariff (what has been traditionally advertised to applicants) and the “common entry” tariff.

On UCAS’s website “common entry” isn’t precisely defined, but my reading is that it represents the mode (the qualifications held by the majority of placed applicants) with the higher and lower tariffs representing the 95th and 5th percentile (the top and bottom five percent of entry tariffs are not used – a statistical process to remove unrepresentative outliers called “winsorisation”.

Who’s been recruiting my students?

And if you’ve been following the discourse around recruitment over recent years, you’ll know that the allegation is that “prestige” providers are lowering tariffs in order to “steal” applicants who otherwise would take places elsewhere. There’s some examples of that – at Birmingham, for instance, the common offer is now lower than the entry tariff, with consequent shifts at the higher and lower bounds. Nottingham shows a more extreme shift, but alongside a drop in student numbers. But in general the trend is in the opposite direction – it is notably harder to get a pharmacy place at the top end of the market than it was a couple of years back.

Because pharmacists are needed right across the country there are places where you can study at a significantly lower tariff – but even here, there is very little evidence of changes in behaviour. And even where tariff signalling has moved downwards (for example, in Sunderland) the actual grades that students hold have not. There are new entrants to the market: Coventry and Worcester are developing courses based on their own existing capacity in pharmacological sciences provision, and providers as diverse as the University of Liverpool and the University of Suffolk are advertising pharmacy for the first time in the 2027 cycle.

One notable innovation has been the start of University of Bath MPharm provision delivered at the University of Plymouth. This is awarded by Bath and taught by Bath academics on the Plymouth campus, an arrangement that I’d not come across before.

How hard is it to get in?

Though there is not a direct link between the tariffs being advertised now and entry rates and tariffs from previous years, the former is clearly a response to the latter. And a general perception that the market is tightening at the low tariff end is playing into the pool of pressures that determine what ends up in the prospectus.

If we look at offer rate – the proportion of applicants from UK 18 and 19 year olds that result in an offer being made – there is not much evidence that there are big changes at the Russell group: the offer rates at KCL and UCL, for example, have pretty much halved alongside a growth in student numbers. At some more locally-focused providers – De Montfort, Bradford, East Anglia – it is a little easier to get an offer, but nothing outlandish has happened.

I’d heard the story about lowering entry requirements and rising offer rates at the Russell Group so often, and from so many people, I had started to believe it. But based on this analysis of a single, small, subject the evidence is not there. In pharmacy, at least, the market is broad and well-served – and there is no evidence of any great movement of applicant populations between providers.



Source link